Pages that link to "Q43901060"
Jump to navigation
Jump to search
The following pages link to Neuro-endocrine cells--a new prognostic parameter in prostate cancer (Q43901060):
Displaying 50 items.
- Isolation and identification of L-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid system (Q24308929) (← links)
- Activated 3',5'-cyclic AMP-dependent protein kinase is sufficient to induce neuroendocrine-like differentiation of the LNCaP prostate tumor cell line (Q30305599) (← links)
- Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer (Q30856653) (← links)
- Pro-neural transcription factors as cancer markers (Q33338632) (← links)
- A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells (Q33585069) (← links)
- Neuroendocrine differentiation in prostatic carcinoma (Q33604393) (← links)
- Cytoskeleton reorganization as an alternative mechanism of store-operated calcium entry control in neuroendocrine-differentiated cells. (Q34438254) (← links)
- Impact of stress on cancer metastasis (Q34569251) (← links)
- A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49 (Q35747677) (← links)
- Neuroendocrine differentiation in human prostatic tumor models (Q35782075) (← links)
- Neuroendocrine Tumors of the Prostate: Emerging Insights from Molecular Data and Updates to the 2016 World Health Organization Classification (Q35925835) (← links)
- Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens (Q35977233) (← links)
- Prostatic carcinoma: a multivariate analysis of prognostic factors (Q35978450) (← links)
- The expression and localisation of beta-nerve growth factor (beta-NGF) in benign and malignant human prostate tissue: relationship to neuroendocrine differentiation (Q36136327) (← links)
- Neuroendocrine differentiation in prostate cancer (Q36537698) (← links)
- Neuroendocrine modulation of cancer progression. (Q37071784) (← links)
- Activin receptor signaling regulates prostatic epithelial cell adhesion and viability (Q37133929) (← links)
- Small cell carcinoma of the prostate (Q38188869) (← links)
- Prognostic effect of neuroendocrine differentiation in prostate cancer: A critical review (Q38252648) (← links)
- Neuroendocrine differentiation of prostate cancer: a review (Q38326554) (← links)
- Mucinous differentiation features associated with hormonal escape in a human prostate cancer xenograft (Q38796817) (← links)
- Evaluation of neuroendocrine staining and androgen receptor expression in incidental prostatic adenocarcinoma: prognostic implications (Q39733396) (← links)
- Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells (Q39999738) (← links)
- Small cell carcinoma of the bladder and prostate (Q40379901) (← links)
- Can aggressive prostatic carcinomas be identified and can their natural history be altered by treatment? (Q40469934) (← links)
- A pathologist's view of prostatic carcinoma (Q40484729) (← links)
- Neuroendocrine cells in the normal, hyperplastic and neoplastic prostate. (Q40519386) (← links)
- Future directions in research of prostate carcinoma (Q40849266) (← links)
- STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells . (Q40905638) (← links)
- Neuroendocrine differentiation in prostatic malignancy (Q41010841) (← links)
- Suppression of the growth and invasiveness of human prostate cancer cells in vitro by neuropeptide antagonist substance P analogues (Q41073949) (← links)
- Characterization and localization of nitric oxide synthase in the human prostate (Q41664812) (← links)
- Proposed morphologic classification of prostate cancer with neuroendocrine differentiation (Q41994427) (← links)
- Long-term assessment of prostate cancer progression free survival: evaluation of pathological parameters, nuclear shape and molecular biomarkers of pathogenesis (Q42120683) (← links)
- In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin (Q42450423) (← links)
- In situ hybridization for gastrin-releasing peptide receptor (GRP receptor) expression in prostatic carcinoma (Q42451938) (← links)
- Cells in various benign and malignant conditions of the human prostate express different antigenic phenotypes (Q42470311) (← links)
- Presence of neuroendocrine cells during postnatal development in rat prostate: Immunohistochemical, molecular, and quantitative study (Q44569680) (← links)
- Modulation of Prostate Carcinoma Cell Growth and Apoptosis by Chromogranin A (Q44610279) (← links)
- Receptor protein tyrosine phosphatase alpha signaling is involved in androgen depletion-induced neuroendocrine differentiation of androgen-sensitive LNCaP human prostate cancer cells (Q44615404) (← links)
- Effect of nonsteroidal antiandrogen monotherapy versus castration therapy on neuroendocrine differentiation in prostate carcinoma (Q44803724) (← links)
- Neuroendocrine cells in the prostate of the rat, guinea pig, cat, and dog (Q46634566) (← links)
- Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone (Q47744334) (← links)
- Expression of prostatic TRH‐like peptides differs between species and between malignant and nonmalignant tissues (Q48390930) (← links)
- Expression and processing of peptidylglycine alpha-amidating monooxygenase messenger RNA in rat prostate (Q48959361) (← links)
- Neuroendocrine tumors of the prostate (Q49347811) (← links)
- Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K-AKT pathway. (Q51066360) (← links)
- Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins (Q52526626) (← links)
- Prognostic significance of neuroendocrine differentiation, proliferation activity and androgen receptor expression in prostate cancer. (Q53397799) (← links)
- Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma. (Q53958238) (← links)